Mirae Asset Global Investments Co., Ltd. Instil Bio, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $22.5 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$4.65 - $7.37 $40,822 - $64,701
8,779 Added 47.22%
27,370 $133,000
Q2 2022

Jul 26, 2022
BUY
$4.21 - $11.15 $78,268 - $207,289
18,591 New
18,591 $86,000

Others Institutions Holding TIL

# of Institutions
2
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Instil Bio, Inc.

TIL Quotes by TradingView
  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.67B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email